ArticleFrontiers in aging neuroscience2022
MPC-STANet: Alzheimer's Disease Recognition Method Based on Multiple Phantom Convolution and Spatial Transformation Attention Mechanism.
Article in Frontiers in aging neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Artificial Intelligence in Biomedicine: A Systematic Review from Nanomedicine to Neurology and Hepatology.Pharmaceutics · 2025Review
- Two-layer dynamic blood phantom for assessing NIRS device accuracy.Biomedical optics express · 2025Article
- Artificial Intelligence in Alzheimer's Disease Diagnosis and Prognosis Using PET-MRI: A Narrative Review of High-Impact Literature Post-Tauvid Approval.Journal of clinical medicine · 2025Review
- Implications of Convolutional Neural Network for Brain MRI Image Classification to Identify Alzheimer's Disease.Parkinson's disease · 2024Article
- c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer's disease.BMC medical genomics · 2023Article
- Improving Alzheimer's Disease Classification in Brain MRI Images Using a Neural Network Model Enhanced with PCA and SWLDA.Healthcare (Basel, Switzerland) · 2023Article
- MOOC and Flipped Classroom Task-Based English Teaching Model for Colleges and Universities Using Data Mining and Few-Shot Learning Technology.Computational intelligence and neuroscience · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disease with insidious and irreversible onset. The recognition of the disease stage of AD and the administration of effective interventional treatment are important to slow down and control the progression of the disease. However, due to the unbalanced distribution of the acquired data volume, the problem that the features change inconspicuously in different disease stages of AD, and the scattered and narrow areas of the feature areas (hippocampal region, medial temporal lobe, etc.), the effective recognition of AD remains a critical unmet need. Therefore, we first employ class-balancing operation using data expansion and Synthetic Minority Oversampling Technique (SMOTE) to avoid the AD MRI dataset being affected by classification imbalance in the training. Subsequently, a recognition network based on Multi-Phantom Convolution (MPC) and Space Conversion Attention Mechanism (MPC-STANet) with ResNet50 as the backbone network is proposed for the recognition of the disease stages of AD. In this study, we propose a Multi-Phantom Convolution in the way of convolution according to the channel direction and integrate it with the average pooling layer into two basic blocks of ResNet50: Conv Block and Identity Block to propose the Multi-Phantom Residual Block (MPRB) including Multi-Conv Block and Multi-Identity Block to better recognize the scattered and tiny disease features of Alzheimer's disease. Meanwhile, the weight coefficients are extracted from both vertical and horizontal directions using the Space Conversion Attention Mechanism (SCAM) to better recognize subtle structural changes in the AD MRI images. The experimental results show that our proposed method achieves an average recognition accuracy of 96.25%, F1 score of 95%, and mAP of 93%, and the number of parameters is only 1.69 M more than ResNet50.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.